Donor leukocyte infusions

Bailliere's Clinical Haematology

Volumn 10, Issue 2, 1997, Pages 357-367

  Mackinnon, S ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Bone marrow transplantation; Chronic myeloid leukaemia; Graft versus leukaemia; Graft versus host disease; Lymphocyte transfusion; Remission induction; T lymphocytes

Indexed keywords

ALPHA INTERFERON; CD8 ANTIGEN; MESSENGER RNA; PROTEIN BCL 2;

ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW APLASIA; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; DONOR; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LEUKOCYTE TRANSFUSION; MINIMAL RESIDUAL DISEASE; MORTALITY; PRIORITY JOURNAL; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; T LYMPHOCYTE; TOXICITY;

EID: 0030766115     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(97)80012-1     Document Type: Article

References (36)

1. (Abstract). Alyea EP Canning C Collins H Efficacy and toxicity of CD4+ donor T lymphocyte infusion for treatment of relapsed chronic myelogenous leukemia after allogeneic BMT Blood 88 supplement 1 1996 682a
2. Antin JH Graft-versus-leukemia: no longer an epiphenomenon Blood 82 1993 2273 2277
3. Apperley JF Jones L Hale G Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft versus host disease but may increase the risk of leukaemic relapse Bone Marrow Transplantation 1 1986 53 68
4. (abstract). Arcese W Goldman JM D'Arcangelo E Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia Blood 82 supplement 1 1993 345
5. Bar BMAM Schattenberg A Mensink EJBM Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation Journal of Clinical Oncology 11 1994 513 519
6. Cross NCP Feng L Chase A Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation Blood 82 1993 1929 1936
7. Drobyski WR Keever CA Roth MS Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose Blood 82 1993 2310 2318
8. Fialkow PJ Gartler SM Yoshida A Clonal origin of chronic myelocytic leukemia in man Proceedings of the National Academy of Sciences of the USA 58 1967 1468 1471
9. Garicochea B Chase A Lazaridou A Goldman JM T-lymphocytes in CML: no evidence of the BCR/ABL fusion gene detected by fluorescence in situ hybridization in 14 patients Leukemia 8 1994 1197 1201
10. Giralt S Hester J Huh Y CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Blood 86 1995 4337 4343
11. Helg C Roux E Beris P Adoptive immunotherapy for recurrent CML after BMT Bone Marrow Transplantation 12 1993 125 129
12. Hertenstein B Wiesneth M Novotny J Interferon-a and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation Transplantation 56 1993 1114 1118
13. Horowitz MM Gale RP Sondel PM Graft-versus-leukemia reactions following bone marrow transplantation in humans Blood 75 1990 555 562
14. Johnson BD Drobyski WR Truit RL Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versushost disease Bone Marrow Transplantation 11 1993 329 336
15. Kaminski E Sharrock C Hows J Frequency analysis of cytotoxic lymphocyte precursors—possible relevance to HLA-matched unrelated donor bone marrow transplantation Bone Marrow Transplantation 3 1988 149 165
16. Kaminski E Hows J Man S Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation Transplantation 48 1989 608 613
17. Kernan NA Collins NH Juliano Clonable T lymphocytes in T-cell depleted bone marrow transplants correlate with development of graft versus host disease Blood 68 1986 770 773
18. Kolb HJ Mittermuller J Clemm Ch Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 76 1990 2462 2465
19. Kolb HJ Schattenberg A Goldman JM Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 86 1995 2041 2050
20. Kolb HJ Mittermuller J Holler E Graft-versus-host reaction spares normal stem cells in chronic myelogenous leukemia Bone Marrow Transplantation 17 1996 449 452
21. Mackinnon S Hows JM Goldman JM In vitro induction of graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia Blood 76 1990 2037 2045
22. Mackinnon S Barnett L Heller G O'Reilly RJ Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia Blood 83 1994 3409 3416
23. Mackinnon S Papadopoulos EP Carabasi MH Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia following bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease Blood 86 1995 1261 1268
24. Mackinnon S Barnett L Heller G Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia Bone Marrow Transplantation 17 1996 643 647
25. Mrsic M Horowitz MM Atkinson K Second HLA-identical sibling transplants for leukemia recurrence Bone Marrow Transplantation 9 1992 269 275
26. Nimer SD Giorgi J Gajewski JL Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone-marrow transplantation—a randomized controlled trial Transplantation 57 1994 82 87
27. Papadopoulos EB Ladanyi M Emanuel D Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation New England Journal of Medicine 330 1994 1185 1191
28. (abstract). Pati AR Godder K Parrish R Pre-emptive therapy with donor leukocyte infusions to prevent relapse following partially mismatched related donor bone marrow transplantation Blood 88 supplement 1 1996 259a
29. Porter DL Roth MS McGarigle C Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia New England Journal of Medicine 330 1994 100 106
30. van Rhee F Lin F Cullis JO Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse Blood 83 1994 3377 3383
31. Schwarer AP Jiang YZ Brookes PA Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone marrow transplantation Lancet 341 1993 203 205
32. Slavin S Naparstek E Nagler A Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation Blood 87 1996 2195 2204
33. Theobald M Nierle T Bunjes D Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings New England Journal of Medicine 327 1992 1613 1617
34. Weiden PL Flournoy N Thomas ED Antileukemic effect of graft versus host disease in recipients of allogeneic marrow grafts New England Journal of Medicine 300 1979 1068 1073
35. Weiss L Reich S Slavin S Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2-activated cell-mediated immunotherapy Cancer Investigation 10 1992 19 26
36. Young JL Percy CL Asire AJ Surveillance epidemiology and results, incidence and mortality data: 1973–1977 National Cancer Institute, Monograph 57 1981 91 95